As we continually monitor the Hub Services Provider market, we want to share some of the company activities that caught our attention.
Claritas Rx announced the closing of a significant growth equity investment from Questa Capital, a venture growth equity firm focused on investing in expansion-stage healthcare companies. The funds will be used to enhance drug and patient analytics with innovative new products, accelerate sales & marketing, and expand the company’s management team. The Claritas Rx data aggregation platform and aggregator-agnostic tools let commercial teams mine data more effectively to engage customers and support patients.
Precision Value & Health
As part of an effort to turbocharge its omnichannel platforms and digital transformation offering, Precision Value & Health is acquiring engagement consultancy Across Health, PV&H announced recently. A consultancy based in Belgium, Across Health specializes in omnichannel strategy within the life-sciences space. Until now, the company’s footprint has mostly been limited to Europe – so the deal simultaneously bolsters Across’ North American presence and PV&H’s overseas operations.
Fishawack Health has acquired PRMA Consulting, a premier global market access and health economics outcomes research (HEOR) consultancy with offices across Europe, Asia, and the US. The acquisition bolsters Fishawack Health’s strong strategic offering, adding deep expertise in Asia-Pacific and European markets to complement the company’s existing market access offering in North America. Fishawack Health now offers one of the industry’s leading market access and HEOR capabilities, spanning the globe. For more than a decade, PRMA Consulting has shaped the future of market access with an industry-leading strategic offering and award-winning, cloud-based digital applications that unlock and optimize product value – the PRMA Healthcheck®, PRMA Navigator®, PRMA Tracker®, and PRMA Access Accelerator®. Fishawack Health intends to make these solutions available to all existing clients.
Diligent Health Solutions
Uniphar plc, Diligent’s parent company, has acquired RRD International, a specialized product development company providing strategic and operational support to biopharmaceutical companies and investors. As does Diligent, RRD will continue to operate autonomously while leveraging the resources and reach of Uniphar.
Eversana unveiled its comprehensive data, technology and services solution to bring the power of real-world data to chronic disease research, evidence generation and patient support. Through the ACTICS by Eversana technology platform, paired with robust outsourced service capabilities in value and evidence research and patient hub services, EVERSANA’s Chronic Disease Real-World Data (RWD) solution enables life sciences stakeholders to conduct regulatory-grade research studies, generate evidence and provide data-driven insight and proactive support to improve the chronic, comorbid patient experience. EVERSANA’s combination of scaled RWD with unstructured content and an expert curation team will enable regulatory-grade, auditable determination of clinical endpoints and scoring used in clinical trials, thus enabling synthetic control comparisons that can speed study times and offer important signals about how
ICON plc, a global provider of outsourced drug and device development and commercialization services to the pharmaceutical, biotechnology and medical device industries, and government and public health organizations, announced it has entered into a definitive agreement to acquire PRA Health Sciences, Inc. in a cash and stock transaction valued at approximately $12 billion. The transaction brings together two high-quality, innovative and growing organizations with similar cultures and a shared focus on high quality and efficient clinical trial execution from Phase 1 to post-approval studies. Biopharma and medical device customers of all sizes will benefit from broader service offerings and geographic footprint, deeper therapeutic expertise, expansive healthcare technology innovation, and functional talent and capabilities. PRA’s mobile and connected health platforms and real world data and information solutions together with ICON’s Accellacare site network, home health services and wearables expertise, will be combined to deliver differentiated decentralized and hybrid trial solutions to meet growing customer needs.
Takeaway: HUB Service Providers continue to position themselves to grow in a very competitive market